(Q38888647)

7 September 2017

title

Leishmaniasis of the tongue treated with liposomal amphotericin B. (English)

1 reference

7 September 2017

Baily GG

1

1 reference

7 September 2017

Pitt MA

2

1 reference

7 September 2017

Curry A

3

1 reference

7 September 2017

Haboubi NY

4

1 reference

7 September 2017

Tuffin JR

5

1 reference

7 September 2017

Mandal BK

6

1 reference

7 September 2017

publication date

1 May 1994

1 reference

7 September 2017

1 reference

7 September 2017

volume

28

1 reference

7 September 2017

issue

3

1 reference

7 September 2017

page(s)

327-331

1 reference

Rectal leishmaniasis in a patient with acquired immunodeficiency syndrome

7 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2894%2992193-8

7 January 2021

Visceral leishmaniasis in patients infected with human immunodeficiency virus. Co-operative Group for the Study of Leishmaniasis in AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2894%2992193-8

7 January 2021

Amphotericin versus pentamidine in antimony-unresponsive kala-azar

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2894%2992193-8

7 January 2021

Aminosidine (paromomycin) in the treatment of leishmaniasis imported into the United Kingdom

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2894%2992193-8

7 January 2021

Successful treatment of antimony-resistant visceral leishmaniasis with liposomal amphotericin B in patients infected with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2894%2992193-8

7 January 2021

10.1016/S0163-4453(94)92193-8

Identifiers

DOI

1 reference

7 September 2017

1 reference